IFNL4 and cryohydrocytosis: Host factors such as polymorphisms at the IL28B/IFNL4 loci and pre-treatment levels of intrahepatic ISG expression seemed less important in determining the outcomes of IFN therapy in chimeric mice than they were in CHC patients.